Clinical Trial Update: Spironolactone for Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating spironolactone for pulmonary arterial hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: RECRUITING